May 26, 2026 09:26AM

Mar 27, 2026 10:44AM

Mar 16, 2026 07:00AM

Feb 27, 2026 10:24AM

Jan 15, 2026 02:07PM

Nov 25, 2025 10:51PM

Nov 25, 2025 10:51PM FDA approves label update for UNLOXCYT™ (cosibelimab-ipdl) based on longer-term data that demonstrated improved clinical outcomes in advanced cutaneous squamous cell carcinoma (aCSCC)

Jul 14, 2025 07:27AM

May 30, 2025 10:39AM

May 16, 2025 08:58AM

Apr 24, 2025 02:28AM

Mar 9, 2025 10:07PM

Mar 9, 2025 10:06PM

Oct 25, 2024 02:21PM Sun Pharma Presents LEQSELVI™ (deuruxolitinib) Data Highlighting Clinical Efficacy & Durability for Treatment of Alopecia Areata at the 2024 Fall Clinical Dermatology Conference

Oct 25, 2024 08:30AM

Oct 25, 2024 07:00AM

Sep 26, 2024 08:00AM

Sep 6, 2024 02:30AM

Jul 26, 2024 10:22AM

Jul 25, 2024 08:09PM

Oct 12, 2023 06:55AM CEQUA® (cyclosporine ophthalmic solution) 0.09% Phase 4 Data Showed Sustained Improvement in Dry Eye Disease Signs and Symptoms in Patients Switched From Restasis® (cyclosporine ophthalmic emulsion)

Mar 6, 2023 08:39AM

Jan 19, 2023 09:39AM

Mar 25, 2022 07:00AM

Nov 1, 2021 07:00AM

Aug 31, 2021 08:05AM

Jul 26, 2021 03:46AM

Feb 25, 2021 05:00AM Sun Pharma Launches Website for its Long-Term Care Portfolio in the U.S.

Sep 23, 2020 07:00AM

Jun 12, 2020 03:21PM

Mar 27, 2020 03:00PM

Feb 26, 2020 05:00AM

Feb 4, 2020 05:46AM

Oct 16, 2019 12:05AM

Oct 15, 2019 07:45AM Sun Ophthalmics to Present Updated CEQUA™ and XELPROS™ Data at AAOPT/WCO 2019

Oct 14, 2019 12:05AM

Jul 17, 2019 07:45AM

Jul 15, 2019 12:10AM

Apr 8, 2019 12:05AM

Mar 1, 2019 07:31AM

Jan 8, 2019 07:30AM

Oct 23, 2018 07:02AM Sun Pharma Announces the Availability of ILUMYA™ (tildrakizumab-asmn) in the United States for the Treatment of Moderate-to-Severe Plaque Psoriasis

Sep 14, 2018 12:05AM

Aug 16, 2018 12:10AM

Aug 9, 2018 05:49PM

Aug 6, 2018 06:45AM

May 23, 2018 12:21AM

May 17, 2018 05:57PM

Mar 29, 2018 07:30AM Crescita Announces Launch of Pliaglis in U.S.

Mar 21, 2018 09:04AM

322,969 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All